Utilizing Machine Learning to Classify Advanced Rheumatic Heart Disease via Electrocardiogram in Cardiology Settings - Report - MDSpire

Utilizing Machine Learning to Classify Advanced Rheumatic Heart Disease via Electrocardiogram in Cardiology Settings

  • By

  • Amsalu Tomas Chuma

  • Melkamu Hunegnaw Asmare

  • Carolina Varon

  • Desalew Mekonnen Kassie

  • Chunzhuo Wang

  • Bart Vanrumste

  • December 1, 2025

  • 0 min

Share

Clinical Report: Utilizing Machine Learning to Classify Advanced Rheumatic Heart Disease

Overview

This study explores the application of machine learning techniques to classify advanced rheumatic heart disease (RHD) using electrocardiogram (ECG) data. The findings suggest that combining time- and frequency-domain features with Convolutional Neural Networks can enhance RHD detection in resource-limited settings.

Background

Rheumatic heart disease remains a significant public health issue, particularly in low- and middle-income countries, where it leads to high morbidity and mortality rates among young adults. Early detection and management are crucial to prevent disease progression, yet challenges such as limited healthcare resources and diagnostic capabilities persist. This study aims to address these challenges by utilizing machine learning for improved RHD classification.

Data Highlights

No numerical data available in the source material.

Key Findings

  • RHD is a preventable condition with significant morbidity and mortality, particularly in low-income regions.
  • Machine learning can automate the detection of RHD from ECG signals, potentially improving diagnostic accuracy.
  • Combining various feature extraction methods with CNNs can enhance the classification of RHD cases.
  • Current echocardiographic methods, while effective, are not always practical in resource-limited settings.
  • ECG remains underutilized for RHD detection due to its indirect reflection of valve pathology.

Clinical Implications

The integration of machine learning in RHD detection could facilitate earlier diagnosis and treatment in resource-limited settings, ultimately improving patient outcomes. Healthcare providers should consider adopting these technologies to enhance diagnostic capabilities and reduce the burden on referral hospitals.

Conclusion

Utilizing machine learning for RHD classification via ECG presents a promising approach to address diagnostic challenges in high-risk populations. This method could significantly improve early detection and management of the disease.

References

  1. Clinical Research in Cardiology, 2022 -- Utilizing Machine Learning for Identifying and Managing Atrial Fibrillation
  2. Pediatric Cardiology, 2025 -- AI-Driven ECG Analysis for Determining Age and Gender in Pediatric Populations
  3. npj Digital Medicine, 2025 -- Interpretable arrhythmia detection in ECG scans using deep learning ensembles: a genetic programming approach
  4. European Radiology, 2024 -- Cine-cardiac MRI for Differentiating Ischemic from Non-Ischemic Cardiomyopathies Using Machine Learning Techniques
  5. 2025 ESC/EACTS Guidelines for the management of valvular heart disease
  6. Machine learning-based analysis of ECG and PCG signals for rheumatic heart disease detection: A scoping review (2015–2025) - ScienceDirect
  7. 2025 ESC/EACTS Guidelines for the management of valvular heart disease
  8. Machine learning-based analysis of ECG and PCG signals for rheumatic heart disease detection: A scoping review (2015–2025) - ScienceDirect
  9. Digoxin Improves Outcomes in Patients With Rheumatic Heart Disease - American College of Cardiology

Original Source(s)

Related Content